Holy_cow
Bluelighter
- Joined
- Nov 29, 2007
- Messages
- 171
RECURRENCE PREVENTIVE THERAPEUTIC AGENT FOR PSYCHOSTIMULANT-INDUCED PSYCHOSIS AND SCHIZOPHRENIA
Publication number: EP1859807
Publication date: 2007-11-28
Inventor: KASHIWA ATSUSHI (JP); NISHIKAWA TORU (JP); KANEKO YUJIRO (JP)
Applicant: TOKYO MEDICAL AND DENTAL UNIVE (JP)
Abstract of EP1859807
So apparently adding a SSRI component to a DARI will prevent the stimulant induced psychosis?
Publication number: EP1859807
Publication date: 2007-11-28
Inventor: KASHIWA ATSUSHI (JP); NISHIKAWA TORU (JP); KANEKO YUJIRO (JP)
Applicant: TOKYO MEDICAL AND DENTAL UNIVE (JP)
Abstract of EP1859807
http://v3.espacenet.com/textdoc?DB=EPODOC&IDX=EP1859807&F=0&QPN=EP1859807The present invention provides a therapeutic agent for preventing recurrence of psychostimulant-induced psychosis and schizophrenia. This therapeutic agent for preventing recurrence of psychostimulant-induced psychosis and schizophrenia includes a drug that amplifies serotonin signals as an active component. This therapeutic agent for preventing recurrence of psychostimulant-induced psychosis and schizophrenia includes a drug that amplifies serotonin signals as an active component. This therapeutic agent for preventing recurrence of psychostimulant-induced psychosis and schizophrenia includes a drug that amplifies serotonin signals as an active component.
So apparently adding a SSRI component to a DARI will prevent the stimulant induced psychosis?
